Merck and Qilu Pharmaceutical Enter into Stable Supply Cooperation Agreement to Advance Biopharmaceutical Development
Qilu Pharmaceutical
Specialty Formulations and Active Pharmaceutical Ingredients (API) Developer
Merck Group
Pharmaceutical R&D Developer
On July 12, 2024, Merck Group, a global leading technology company, announced a stable supply cooperation agreement with Qilu Pharmaceutical Group. Through resource sharing, mutual benefit, and enhancing supply chain stability, both parties will jointly promote the launch of more affordable domestically produced medicines and advance the development of the biopharmaceutical field.
Signing Guests (from left to right)
Zhao Weiliang, General Manager of the Material Management Center of Qilu Pharmaceutical Group
Fan Yang, General Manager of Merck Life Science China Process Solutions
Both parties will fully leverage their respective strengths to jointly advance the commercialization of the project, contributing more high-quality yet affordable drugs for the treatment of tumors, cardiovascular and cerebrovascular diseases, infections, psychiatric disorders, neurological conditions, and ophthalmic diseases in clinical settings.
Yang Fan, General Manager of Merck Life Science China Process Solutions, said:
As a German technology company with over 350 years of history, Merck Group actively collaborates with partners to lead the way in life sciences and health through innovation. We will leverage our strengths to effectively enhance the efficiency of biopharmaceutical R&D and production, while strengthening the safety and sustainability of the product supply chain.Merck will provide annual stocking orders for Qilu Pharmaceutical to ensure product quality and stable supply.
Zhao Weiliang, General Manager of the Material Management Center of Qilu Pharmaceutical Group, said:
As a leading enterprise in China's biopharmaceutical field, Qilu Pharmaceutical upholds the core values of "Great Medicine with Sincerity, Family and Country for the World," taking industrial contribution to the nation as its mission, driven by innovation, and always focusing on the forefront of global technology and the health of people’s lives. Qilu Pharmaceutical is willing to join hands with Merck Group to contribute to the cause of human life and health.
About Merck Process Solutions
Merck Process Solutions provides comprehensive support to pharmaceutical customers with reliable products, extensive pharmaceutical process expertise, and excellent regulatory support, addressing various process challenges.
